Genetic testing is a powerful tool that allows for the detection of BRCA and non-BRCA germline mutations in individuals with high risks of breast cancer, which in turn aids in the individualization of treatment. Given the magnitude of this disease, it is of great benefit for physicians, including general surgeons, to understand the indications, interpretations, and costs associated with genetic testing in patients with breast cancer. Cost is an especially important part of the genetic testing process and point of discussion with patients.

HighlightsPrimary small cell neuroendocrine carcinoma of the breast is a very rare diagnosis.It has similar features to small cell neuroendocrine carcinoma of the lung.Diagnostic workup must exclude metastasis from another primary site.Treatment combines approaches for more common types of lung and breast cancer.Further studies are needed to standardized the treatment for primary SCNCB.

HighlightsHidradenitis suppurativa is a chronic inflammatory disease of the skin.Management differs based on severity of disease but also focuses on prevention.Surgical treatment of hidradenitis of the breast in pregnancy is presented.